A discussion highlighting the importance of considering those with learning and intellectual disabilities when implementing changes in practice related to valproate prescribing. Lance and Maria explore the potential impact on the system and suggest considerations to promote an equitable and safe journey for the valproate patient with learning and intellectual disabilities (23m 37s).

Speakers:

Professor Lance Watkins: Consultant psychiatrist; Visiting Professor (University of South Wales); Associate Professor (University of Plymouth); Clinical Lead for Learning Disability Research (NCMH); Epilepsy Pathway Lead (Swansea University Health Board).

Dr Maria Vincent: GP Specialist in Learning Disability Medicine (Swansea University Health Board)

Anna Bischler: Lead Pharmacist - Medicines Safety, SPS